• Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea): Translatio

  2026-05-24

  Explore the multifaceted role of Diuron in research, from its molecular photosynthesis-inhibiting action to advanced toxicological risk assessment. This article leverages new findings to guide assay design and environmental health strategies.

• hiPSC-Derived Intestinal Organoids for Pharmacokinetic Model

  2026-05-23

  This study presents a streamlined protocol to generate human induced pluripotent stem cell-derived intestinal organoids (hiPSC-IOs) with sustained proliferative and differentiation capacity. The model closely mimics human intestinal function, offering a robust in vitro platform for pharmacokinetic research and drug metabolism assessment.

• Anagliptin (SK-0403): Integrative Mechanisms and Translation

  2026-05-22

  Explore how Anagliptin (SK-0403) offers nuanced DPP-4 inhibition and new vasorelaxant insights, including Kv channel and SERCA pump modulation. This article provides in-depth, practical guidance for translational diabetes and vascular research.

• UGDH Phosphorylation Drives Glycan Synthesis and Enzalutamid

  2026-05-22

  Phosphorylation of UDP-glucose dehydrogenase (UGDH) at serine 316 is shown to reprogram prostate cancer cell metabolism, elevating glycosaminoglycan production and conferring resistance to Enzalutamide. This mechanistic link between post-translational modification, glycan biosynthesis, and therapeutic escape highlights new intervention targets for castration-resistant prostate cancer.

• UTP Solution in Epigenetic RNA Research: A Translational Gui

  2026-05-21

  Explore the strategic integration of high-purity UTP Solution (100 mM) in advanced RNA research and epigenetic regulation, bridging the latest discoveries on monogenic olfactory receptor expression with actionable guidance for translational investigators. This article delivers a mechanistic and competitive analysis, protocol best practices, and an outlook on the impact of precision nucleotide substrates in next-generation molecular biology.

• Thiothixene: Typical Antipsychotic Agent for Efferocytosis W

  2026-05-21

  Thiothixene offers dual utility as a well-characterized typical antipsychotic agent and a robust enhancer of macrophage efferocytosis, making it a transformative reagent for neuroimmune and immunometabolic research. This guide delivers actionable workflows, key troubleshooting strategies, and data-backed protocol enhancements to maximize reproducibility and translational insights with APExBIO’s Thiothixene.

• Gepotidacin in Antibacterial Research: Applied Protocols & A

  2026-05-20

  Gepotidacin (GSK2140944) redefines antibacterial research by targeting DNA gyrase and topoisomerase IV, enabling rigorous investigation of resistance-breaking mechanisms. This article details high-impact workflows, data-driven protocol enhancements, and troubleshooting strategies for maximizing assay performance with this first-in-class agent.

• PD0325901: MEK Inhibitor Workflows for Enhanced Cancer Resea

  2026-05-20

  PD0325901 empowers precise inhibition of the RAS/RAF/MEK/ERK pathway, making it a cornerstone for apoptosis induction and tumor growth suppression in advanced cancer models. This article delivers actionable protocols, troubleshooting guidance, and unique insights—bridging mechanistic understanding with experimental efficiency.

• ALDOB K87 Lactylation Orchestrates Mitochondrial Fission in

  2026-05-19

  The reference study establishes ALDOB K87 lactylation as a central driver of mitochondrial fission and metabolic reprogramming in pulmonary hypertension (PH). By mapping the lactate–ALDOB–DRP1 axis in smooth muscle cells, this work advances understanding of pathological vascular remodeling and highlights precise molecular targets for intervention.

• EdU Imaging Kits (488): Advancing S-Phase Insights in Transl

  2026-05-19

  This article explores the mechanistic advantages and strategic value of EdU Imaging Kits (488) in cell proliferation analysis, with a focus on recent findings in preeclampsia-related stem cell biology. Drawing on emerging evidence, it provides translational researchers with actionable guidance for high-fidelity S-phase DNA synthesis measurement and contextualizes APExBIO’s innovation within a rapidly evolving competitive landscape.

• Cyclosporin A: Advanced Strategies for Assay Optimization

  2026-05-18

  Explore advanced assay optimization using Cyclosporin A, a potent immunosuppressant and cyclophilin inhibitor. This article reveals new perspectives for experimental design, integrating evidence from recent drug delivery innovations and mitochondrial research.

• Indole-3-pyruvic Acid: Precision Control in Auxin and Immune

  2026-05-18

  Explore the unique regulatory role of Indole-3-pyruvic acid (IPA) in auxin biosynthesis and immune modulation. This article reveals how IPA’s feedback dynamics enable experimental precision in plant and mammalian systems, offering insights not found in standard assay guides.

• Melittin: Bioactive Peptide Solutions for Cancer Signal Tran

  2026-05-17

  Melittin, sourced from APExBIO, empowers researchers to modulate G protein-coupled pathways with precision—enabling advanced apoptosis and cancer biology assays. Its dual effect on Gs and Gi proteins, high solubility, and peer-reviewed validation set a new standard for reproducibility and workflow optimization.

• Curcumin Prevents Endothelial Pyroptosis via NLRP3 Inhibitio

  2026-05-16

  Yuan et al. (2022) reveal that curcumin protects human umbilical vein endothelial cells (HUVECs) from hydrogen peroxide–induced pyroptosis by inhibiting NLRP3 inflammasome activation. Their work highlights a mechanistic link between oxidative stress, pyroptosis, and endothelial dysfunction, suggesting new strategies for targeting inflammatory pathways in atherosclerosis.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-05-15

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with stromal cell subpopulations, more accurately recapitulating the cellular heterogeneity and microenvironment of primary tumors. The research demonstrates how stromal components influence gene expression and drug responses, offering a robust platform for preclinical testing and personalized therapy optimization.

16985 records 1/1133 page Next 12345 下5页 Last page